Psychosurgery involves the surgical alteration of brain tissue to treat severe psychological disorders. Prefrontal lobotomy and cingulotomy are historical and modern examples of such procedures, which are used only as a last resort when other treatments have failed to alleviate severe symptoms.

Behavioral and pharmacological (drug) therapies are primarily symptom-focused. They aim to provide rapid relief from distressing symptoms by modifying observable behaviors or correcting neurochemical imbalances, rather than engaging in the long-term, intensive process of restructuring the underlying personality or unconscious conflicts.

Psychopharmacology is the scientific study of the effects of drugs on mood, sensation, thinking, and behavior. It focuses on how chemical substances interact with the brain's neurotransmitter systems to alter psychological states. This field is essential for understanding how pharmacological interventions can be used to treat various mental health conditions by modulating brain chemistry.

Psychopharmacotherapy is a branch of psychiatry and psychology that focuses on the use of pharmaceutical agents to treat mental health conditions. By targeting specific neurotransmitter systems in the brain, these medications help regulate mood, cognition, and behavior. It is distinct from psychotherapy, which relies on verbal interaction and behavioral techniques to facilitate change.

Transcranial Magnetic Stimulation (TMS) is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain. It is primarily used to treat major depressive disorder and other mental health conditions when other treatments have proven ineffective. By delivering magnetic pulses to specific regions of the brain, TMS can modulate neural activity, making it a form of brain stimulation therapy rather than a pharmacological intervention.

Drug therapies, or psychopharmacology, operate on the biomedical model. This perspective posits that many psychological disorders stem from dysfunctions in neurotransmitter systems or hormonal pathways within the brain. By using medication to restore or regulate these chemical levels, clinicians aim to alleviate symptoms, assuming that correcting the underlying chemical imbalance will improve the patient's psychological state.

SSRIs are a class of antidepressant medications that increase serotonin levels in the brain. They are widely prescribed for depressive disorders to improve mood regulation. Furthermore, clinical research has demonstrated their efficacy in treating obsessive-compulsive disorder (OCD) by helping to reduce the frequency and intensity of intrusive thoughts and repetitive behaviors.

A frequent critique of drug therapy is that it primarily manages symptoms by altering neurochemistry rather than addressing the psychological, environmental, or behavioral root causes of a disorder. While effective for symptom reduction, critics argue that without concurrent psychotherapy, the underlying issues remain unresolved.

The therapist's focus on the spouse's behavior as a potential contributing factor to the patient's addiction indicates a systemic approach. Family therapists view the individual's problems as being embedded within the context of their family dynamics and relationships. By analyzing these interactions, the therapist aims to improve communication and resolve conflicts that may be reinforcing the maladaptive behavior.

Psychiatrists are medical doctors (MD or DO) who have completed medical school and specialized residency training in psychiatry. Unlike psychologists, who typically hold doctoral degrees in psychology (PhD or PsyD) and focus on psychotherapy and psychological testing, psychiatrists are licensed to prescribe medication and manage the biological aspects of mental health disorders.